Tildrakizumab in real-life shows good efficacy in moderate-to-severe psoriasis regardless of previous use of biologic drugs and joint involvement.
作者信息
Mastorino Luca, Cariti Caterina, Susca Sara, Sciamarrelli Nadia, Borriello Silvia, Ortoncelli Michela, Stroppiana Elena, Verrone Anna, Dapavo Paolo, Quaglino Pietro, Ribero Simone
机构信息
Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, Italy.
出版信息
Dermatol Ther. 2022 Nov;35(11):e15818. doi: 10.1111/dth.15818. Epub 2022 Sep 22.
PMID:36097346
Abstract
摘要
Zotero 插件